Search results
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 7 hours agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Is This a Setback for Moderna? | The Motley Fool
The Motley Fool· 1 day agoA potential approval will also show that Moderna isn't just a one-product company and instead can build a billion-dollar respiratory vaccine portfolio,...
AstraZeneca pulls its COVID-19 vaccine from the European market
WSB-TV 2 Atlanta· 7 days agoLONDON — (AP) — The pharma giant AstraZeneca has requested that the European authorization for its...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 5 days agoThe FDA has informed Moderna that it is working to conclude...
Novavax Stock Just Tripled. Is It Too Late to Buy? | The Motley Fool
The Motley Fool· 7 hours agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NVAX -9.80%) stock has...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 5 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 5 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 5 days agoThe Food and Drug Administration's move prolongs the wait for Moderna's second approved product, but...